Dr. Hönle AG/€HNL
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Dr. Hönle AG
Dr. Hönle AG is a company based in Germany that operates within the engineering industry, specializing in the production and sales of industrial UV technology. The company's core business involves developing and manufacturing systems for drying inks and coatings, as well as providing equipment for adhesive bonding and disinfecting surfaces. Among its key products are UV curing devices, IR heaters, and air disinfection systems. Headquartered in Gräfelfing, Germany, Dr. Hönle AG serves a diverse global market, enhancing its competitive edge through specialized expertise in UV technology applications. Its strategic positioning is bolstered by a focus on technological innovation and adaptation to various industrial applications.
Ticker
€HNL
Sector
Primary listing
XETRA
Industry
Electrical Equipment
Headquarters
Employees
540
ISIN
DE0005157101
Website
Dr. Hönle AG Metrics
BasicAdvanced
€57M
-
-€2.14
1.45
-
Price and volume
Market cap
€57M
Beta
1.45
52-week high
€11.90
52-week low
€9.42
Financial strength
Current ratio
1.856
Quick ratio
0.735
Long term debt to equity
46.347
Total debt to equity
66.136
Interest coverage (TTM)
0.14%
Profitability
EBITDA (TTM)
4.669
Gross margin (TTM)
61.59%
Net profit margin (TTM)
-13.24%
Operating margin (TTM)
0.29%
Effective tax rate (TTM)
-7.43%
Revenue per employee (TTM)
€180,000
Management effectiveness
Return on assets (TTM)
0.11%
Return on equity (TTM)
-14.69%
Valuation
Price to revenue (TTM)
0.588
Price to book
0.72
Price to tangible book (TTM)
0.86
Price to free cash flow (TTM)
31.181
Free cash flow yield (TTM)
3.21%
Free cash flow per share (TTM)
30.40%
Growth
Revenue change (TTM)
-3.15%
Earnings per share change (TTM)
-9.85%
3-year revenue growth (CAGR)
-6.18%
10-year revenue growth (CAGR)
1.31%
3-year earnings per share growth (CAGR)
46.10%
10-year earnings per share growth (CAGR)
4.32%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Dr. Hönle AG stock?
Dr. Hönle AG (HNL) has a market cap of €57M as of July 01, 2025.
What is the P/E ratio for Dr. Hönle AG stock?
The price to earnings (P/E) ratio for Dr. Hönle AG (HNL) stock is 0 as of July 01, 2025.
Does Dr. Hönle AG stock pay dividends?
No, Dr. Hönle AG (HNL) stock does not pay dividends to its shareholders as of July 01, 2025.
When is the next Dr. Hönle AG dividend payment date?
Dr. Hönle AG (HNL) stock does not pay dividends to its shareholders.
What is the beta indicator for Dr. Hönle AG?
Dr. Hönle AG (HNL) has a beta rating of 1.45. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.